FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs

Insys’ Kapoor, Four Deputies, Go Down on Racketeering Charges

May 9, 2019
A A

Insys founder John Kapoor is facing up to 20 years in federal prison after a Boston jury convicted him of running a criminal conspiracy to bribe doctors to improve sales of Insys’ ultra-potent opioid Sybsys.

Kapoor, who was once listed as one of the nation’s wealthiest men, was convicted under the Racketeer Influenced and Corrupt Organizations (RICO) laws designed to snare mobsters.

Prosecutors alleged that Kapoor and Insys used “speakers’ bureaus” and other kickbacks to get doctors to prescribe Subsys, a form of fentanyl designed to help late-stage cancer patients manage pain.

View today's stories